Peloton Therapeutics, Inc. Stock
Equities
PLTX
US70614L1044
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Corporate Officer/Principal | - | - | |
Peter Stenge
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helen Kim
BRD | Director/Board Member | 61 | 17-10-31 |
Brett A. Ringle
BRD | Director/Board Member | 73 | 10-12-31 |
David Chang
BRD | Director/Board Member | 64 | 18-01-31 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.31% | 22.2B | |
-16.53% | 21.23B | |
-8.75% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |